Exicure Inc’s Stock Volatility Highlights Biotech Sector’s High Stakes and Innovation Potential
Exicure Inc, a clinical-stage biotech firm, has experienced significant stock price fluctuations, highlighting the risks and uncertainties of the biotech sector despite its promising innovative approach to drug development.
2 minutes to read